Alyeska Investment Group »

Monopar Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $998k 12k 81.67

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Apple (AAPL)
salesforce (CRM)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Take-Two Interactive Software (TTWO)
Microsoft Corporation (MSFT)
Coherent Corp (COHR)
Home Depot (HD)
McDonald's Corporation (MCD)
Twilio Cl A (TWLO)
Arista Networks Com Shs (ANET)

View all positions for Alyeska Investment Group

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics